μ-Opioid agonist-stimulated [35S]GTPγ s binding in guinea pig hypothalamus: Effects of estrogen

Brain Research

Volumn 791, Issue 1-2, 1998, Pages 341-346

  Cunningham, Matthew J ^a   Fang, Yuan ^a   Selley, Dana E ^b   Kelly, Martin J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Opioid receptor; Baclofen; DAMGO; Estrogen; G protein; GTP S

Indexed keywords

ESTROGEN; GUANOSINE TRIPHOSPHATE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; POTASSIUM CHANNEL;

ANIMAL TISSUE; ARTICLE; DRUG EFFECT; ESTROGEN METABOLISM; GUINEA PIG; HYPOTHALAMUS; NONHUMAN; OVARY CYCLE; PAIN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ANIMALS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALINS; ESTROGENS; FEMALE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); GUINEA PIGS; HYPOTHALAMUS; NEUROSECRETORY SYSTEMS; POTASSIUM CHANNELS; RADIOLIGAND ASSAY; RECEPTORS, OPIOID, MU; STIMULATION, CHEMICAL; SULFUR RADIOISOTOPES;

EID: 0032571745     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00201-7     Document Type: Article

References (59)

1. 2-agonists in locus coeruleus neurons. Brain Res. 371:1986;390-394.
2. Akil H., Watson S.J., Young E., Lewis M.E., Khachaturian H., Walker J.M. Endogenous opioids: biology and function. Annu. Rev. Neurosci. 7:1984;223-255.
3. Albright A.L., Lee P.A. Neurosurgical treatment of hypothalamic hamartomas causing precocious puberty. J. Neurosurg. 78:1993;77-82.
4. Bouvier C., Lagace G., Collu R. G protein modulation by estrogens. Mol. Cell Endocrinol. 79:1991;65-73.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
6. Brown L.L., Pasi S., Etgen A.M. Estrogen regulation of μ opioid receptor density in hypothalamic premammillary nuclei. Brain Res. 742:1996;347-351.
7. Bunzow J.R., Zhang G., Bouvier C., Saez C., Rönnekleiv O.K., Kelly M.J., Grandy D.K. Characterization and distribution of a cloned rat μ opioid receptor. J. Neurochem. 64:1995;14-24.
8. Cohen-Tannoudji J., Mhaouty S., Elwardy-Merezak J., Lecrivain J.-L., Robin M.-T., Legrand C., Maltier J.-P. Regulation of myometrial Gi2, Gi3, and Gq expression during pregnancy. Effects of progesterone and estradiol. Biol. Repro. 53:1995;55-64.
9. Cox B.M., Chavkin C. Properties of receptors mediating opioid effects: Discrimination of receptor types. Natl. Inst. Drug Abuse Res. Monogr. Ser. 71:1986;1-18.
10. Di Chiara G., North R.A. Neurobiology of opiate abuse. Trends Pharmacol. Sci. 13:1992;185-193.
11. Dondi D., Limonta P., Maggi R., Piva F. Effects of ovarian hormones on brain opioid binding sites in castrated female rats. Am. J. Physiol. 263:1992;E507-E511.
12. Eipper B.A., Mains R.E. Structure and biosynthesis of pro-adrenocorticotropin/endorphin and related peptides. Endocr. Rev. 1:1980;1-27.
13. Etgen A.M., Petitti N. Mediation of norepinephrine-stimulated cyclic AMP accumulation by adrenergic receptors in hypothalamic and preoptic area slices: effects of estradiol. J. Neurochem. 49:1987;1732-1739.
14. 2-like receptor binding densities. Dev. Brain Res. 104:1997;163-174.
15. Goldstein A. Binding selectivity profiles for ligands of multiple receptor types: focus on opioid receptors. Trends Pharmacol. Sci. 8:1987;456-459.
16. Goldstein A., Naidu A. Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Mol. Pharmacol. 36:1989;265-272.
17. Hilf G., Gierschik P., Jakobs K.H. Muscarinic acetylcholine receptor-stimulated binding of guanosine 5′-O-(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes. Eur. J. Biochem. 186:1989;725-731.
18. Hruska R.E., Nowak M.W. Estrogen treatment increases the density of D1 dopamine receptors in the rat striatum. Brain Res. 442:1988;349-350.
19. Kalra S.P., Kalra P.S. Opioid-adrenergic-steroid connection in regulation of luteinizing hormone secretion in the rat. Neuroendocrine. 38:1984;418-426.
20. 1b-adrenoceptor mRNA in female rat hypothalamus-preoptic area. J. Neuroendocrinol. 8:1996;449-455.
21. Kelly M.J., Loose M.D., Rönnekleiv O.K. Opioids hyperpolarize β-endorphin neurons via μ-receptor activation of a potassium conductance. Neuroendocrine. 52:1990;268-275.
22. B-mediated hyperpolarization of hypothalamic arcuate neurons. J. Neurosci. 12:1992;2745-2750.
23. Kennedy C., Henderson G. μ-Opioid receptor inhibition of calcium current: Development of homologous tolerance in single SH-SY5Y cells after chronic exposure to morphine in vitro. Mol. Pharmacol. 40:1991;1000-1005.
24. Khachaturian H., Lewis M.E., Haber S.N., Akil H., Watson S.J. Proopiomelanocortin peptide immunocytochemistry in rhesus monkey brain. Brain Res. Bull. 13:1984;785-800.
25. Koob G.F. Drugs of abuse: Anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:1992;177-184.
26. 1-Adrenergic agonists act on the ventromedial hypothalamus to cause neuronal excitation and lordosis facilitation: Electrophysiological and behavioral evidence. Brain Res. 588:1992;237-245.
27. Krey L.C., Silverman A.J. The luteinizing hormone-releasing hormone (LHRH) neuronal networks of the guinea pig brain: II. The regulation on gonadotropin secretion and the origin of terminals in the median eminence. Brain Res. 157:1978;247-255.
28. Lagrange A.H., Rönnekleiv O.K., Kelly M.J. The potency of μ-opioid hyperpolarization of hypothalamic arcuate neurons is rapidly attenuated by 17β-estradiol. J. Neurosci. 14:1994;6196-6204.
29. Lagrange A.H., Rönnekleiv O.K., Kelly M.J. Estradiol-17β and μ-opioid peptides rapidly hyperpolarize GnRH neurons: A cellular mechanism of negative feedback? Endocrine. 136:1995;2341-2344.
30. Lagrange A.H., Rönnekleiv O.K., Kelly M.J. Modulation of G protein-coupled receptors by an estrogen receptor that activates protein kinase A. Mol. Pharmacol. 51:1997;605-612.
31. B response in hypothalamic neurons. Neuroendocrine. 64:1996;114-123.
32. Levesque D., Paolo T.Di Chronic estradiol treatment increases ovariectomized rat striatal D-1 dopamine receptors. Life Sci. 45:1989;1813-1820.
33. Loose M.D., Kelly M.J. Opioids act at μ-receptors to hyperpolarize arcuate neurons via an inwardly rectifying potassium conductance. Brain Res. 513:1990;15-23.
34. Loose M.D., Rönnekleiv O.K., Kelly M.J. Membrane properties and response to opioids of identified dopamine neurons in the guinea pig hypothalamus. J. Neurosci. 10:1990;3627-3634.
35. B and μ-opioid receptor agonists: evidence for convergence at a ligand-gated potassium conductance. Neuroendocrine. 54:1991;537-544.
36. Maus M., Bertrand P., Drouva S., Rasolonjanahary R., Kordan C., Glowinski J., Prémont J., Enjalbert A. Differential modulation of D1 and D2 dopamine-sensitive adenylate cyclases by 17β-estradiol in cultured striatal neurons and anterior pituitary cells. J. Neurochem. 52:1989;410-418.
37. o,i protein subunits. J. Neurochem. 55:1990;1244-1251.
38. Millan M.J., Herz A. The endocrinology of the opioids. Int. Rev. Neurobiol. 26:1985;1-83.
39. o-type GTP-binding protein. J. Neurosci. 14:1994;3842-3851.
40. Neer E.J. Intracellular signalling: turning down G-protein signals. Curr. Biol. 7:1997;R31-R33.
41. Olson G.A., Olson R.D., Kastin A.J. Endogenous opiates: 1987. Peptides. 10:1989;205-236.
42. Olson G.A., Olson R.D., Kastin A.J. Endogenous opiates: 1992. Peptides. 14:1993;1339-1378.
43. Paterson S.J., Robsen L.E., Kosterlitz H.W. Classification of opioid receptors. Br. Med. Bull. 39:1983;31-36.
44. 1B-noradrenergic receptors in the hypothalamus and preoptic area. J. Neurosci. 12(10):1992;3869-3876.
45. Piva F., Maggi R., Limonta P., Motta M., Martini L. Effect of naloxone on luteinizing hormone, follicle-stimulating hormone, and prolactin secretion in the different phases of the estrous cycle. Endocrine. 117:1985;766-772.
46. Raynor K., Kong H., Chen Y., Yasuda K., Yu L., Bell G.I., Reisine T. Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptors. Mol. Pharmacol. 45:1994;330-334.
47. Reisine T., Bell G. Molecular biology of opioid receptors. Trends Neurosci. 16:1993;506-510.
48. Ross E.M. G protein GTPase-activating proteins: regulation of speed, amplitude, and signaling selectivity. Recent Prog. Horm. Res. 50:1995;207-221.
49. Rönnekleiv O.K., Bosch M.A., Cunningham M.J., Wagner E.J., Grandy D.K., Kelly M.J. Down regulation of μ-opioid receptor mRNA in the mediobasal hypothalamus of the female guinea pig following morphine treatment. Neurosci. Lett. 216:1996;129-132.
50. 2+ currents, but spares a sustained current. Neuron. 6:1991;13-20.
51. Selley D.E., Breivogel C.S., Childers S.R. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: Increase in opioid agonist efficacy by decreased inactivation of G proteins. Mol. Pharmacol. 44:1993;731-741.
52. 35S ]Guanylyl-5′-O-(γ-thio)-triphosphate binding in guinea pig brain J. Comp. Neurol. 386:1997;562-572.
53. 35S ]thiol]-triphosphate binding Proc. Natl. Acad. Sci. U.S.A. 92:1995;7242-7246.
54. 35S ]thio) triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells Mol. Pharmacol. 47:1995;848-854.
55. Ungar S., Makman M.H., Morris S.A., Etgen A.M. Estrogen uncouples β-adrenergic receptor from the stimulatory guanine nucleotide binding protein in female rat hypothalamus. Endocrine. 133(6):1993;2818-2826.
56. Williams J.T., North R.A., Tokimasa T. Inward rectification of resting and opiate-activated potassium currents in rat locus coeruleus neurons. J. Neurosci. 8:1988;4299-4306.
57. Yu V.C., Eiger S., Duan D.-S., Lameh J., Sadee W. Regulation of cyclic AMP by the μ-opioid receptor in human neuroblastoma SH-SY5Y cells. J. Neurochem. 55(4):1990;1390-1396.
58. Yu V.C., Sadee W. Efficacy and tolerance of narcotic analgesics at the μ opioid receptor in differentiated human neuroblastoma cells. J. Pharmacol. Exp. Ther. 245:1988;350-355.
59. Zhang G., Murray T.F., Kelly M.J. Effect of estrogen on μ-opioid receptor G-protein coupling in guinea-pig mediobasal hypothalamus (MBH). Soc. Neurosci. Abstr. 19:1993;1154.